Investment ThemesDetailed Quotes
CAR-T Therapy
Watchlist
- 1029.362
- +0.656+0.06%
Close Nov 13 16:00 ET
1031.150High1021.968Low
1026.968Open1028.706Pre Close87.05MVolume3Rise16.14P/E (Static)5.12BTurnover--Flatline0.61%Turnover Ratio1.10TMarket Cap7Fall1.08TFloat Cap
Constituent Stocks: 10Top Rising: PFE+2.02%
● Cash / liquidity position: As of September 30, 2024, Adaptimmune had cash and cash equivalents of $116.7 million and Total Liquidity2 of $186.1 million, compared to $144.0 million and $146.9 million respectively, as of December 31...
down
again
do
u
diva gal dive
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
The unit, now called Pfizer Hospital, was formed after Pfizer bought Hospira for about $17 billion in 2015. The pharma giant has hired Goldman Sachs to gauge initial interest from potential buyers, which include private equity firms and other phar...
Looking back at my recent investment decisions, I realized there were some interesting psychological factors at play. I had predicted that Tesla would likely surge following Trump’s successful election, yet I chose to invest in Pfizer instead—a stock that seemed “on the ground” with little attention from the market. In my mind, where the hype fades, potential often emerges. I believed th...
No comment yet